Aim & Scope
Aim
The European Journal of Emerging BioMed Research (EJEBR) aims to advance the frontiers of biomedical science by publishing high-quality, original, and innovative research focused on emerging trends, technologies, and advancements in healthcare and life sciences. The journal serves as a global platform for scientists, clinicians, researchers, and healthcare practitioners to share novel insights, strengthen evidence-based medical practice, and promote breakthrough discoveries that can improve human health and wellbeing.
EJEBR is committed to nurturing global research collaboration, encouraging multidisciplinary studies, and ensuring rapid yet rigorous peer-review to support the scientific community and healthcare innovation ecosystem.
Scope
EJEBR accepts and publishes scholarly contributions from diverse biomedical domains, including fundamental biological research, translational medicine, clinical studies, and health technology advancements. The journal welcomes original research articles, systematic reviews, case reports, mini-reviews, short communications, and innovative hypothesis papers.
Major areas of interest include, but are not limited to:
Biomedical & Life Sciences
-
Molecular and Cellular Biology
-
Genetics, Genomics & Proteomics
-
Microbiology & Infectious Diseases
-
Immunology & Vaccine Research
-
Cancer Biology & Oncology
-
Neuroscience and Neurobiology
Medical & Clinical Research
-
Clinical Sciences & Medical Case Studies
-
Translational & Regenerative Medicine
-
Pharmacology, Toxicology & Therapeutics
-
Pathology & Laboratory Medicine
-
Public Health & Epidemiology
-
Healthcare Policy and Medical Ethics
Emerging Technologies in Medicine
-
Biomedical Engineering & Medical Devices
-
Tissue Engineering & Biomaterials
-
AI, Machine Learning & Data Science in Medicine
-
Bioinformatics & Computational Biology
-
Telemedicine & Digital Healthcare
-
Precision Medicine & Personalized Therapy
Special Themes
-
Gene Editing & CRISPR Technologies
-
Nanomedicine & Drug Delivery Systems
-
Stem Cell Research & Cellular Therapies
-
Biotechnology & Biomedical Innovations
Publication Ethics & Quality
EJEBR follows strict ethical practices guided by COPE and employs a double-blind peer-review system to ensure academic integrity, originality, and scientific excellence. The journal provides global open-access publication with DOI assignment for enhanced research visibility and citation impact.